Dr Thomas P. Burris This is Me

Education

 View all 11 references Web References

1. 1. molpharm.aspetjournals.org

   molpharm.aspetjournals.org/mis - [Cached]

   Published on: 8/18/2007   Last Visited: 8/18/2007

   THOMAS P. BURRIS, Lilly Research Labs

2. 2. Meetings

   www.midwestteratology.org/regi - [Cached]

   Published on: 11/5/2004   Last Visited: 12/8/2005

   10:00 - 10:50 a.m. Regulation of Carbohydrate Metabolism by LXR and FXR (Thomas Burris, Ph.D., Research Advisor, Eli Lilly and Company)

3. 3. The Endocrine Society: Government Affairs and Public Relations

   www.endo-society.org/pubrelati - [Cached]

   Published on: 9/30/2001   Last Visited: 11/3/2002

   Vaginal bleeding in the postmenopausal woman frequently requires careful and potentially invasive evaluation to rule out endometrial cancer, notes Tom Burris, Ph.D., the study's principal investigator and a research scientist at Eli Lilly and Company. A positive step forward in the treatment of breast cancer would be to develop a therapeutic option that is safe and effective without endometrial stimulation.
   
   Additional background information:
   
   This pre-clinical study used a very sensitive model of uterine stimulation known as the Ishikawa endometrial cell line.